Toja-Camba, F. J., Hermelo Vidal, G., Vidal-Millares, M., Durán-Maseda, M. J., Rial Pérez, A., Maroñas, O., . . . Mondelo García, C. (2024). Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment.
Citación estilo ChicagoToja-Camba, Francisco José, et al. Role of CYP2D6 and CYP3A4 Polymorphisms On Aripiprazole and Dehydroaripiprazole Concentrations in Patients Undergoing Long-acting Treatment. 2024.
Cita MLAToja-Camba, Francisco José, et al. Role of CYP2D6 and CYP3A4 Polymorphisms On Aripiprazole and Dehydroaripiprazole Concentrations in Patients Undergoing Long-acting Treatment. 2024.
Precaución: Estas citas no son 100% exactas.